Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2035

Annual patent cliff calendar for 2035 — US pharmaceutical patents by expiration date.

Patents
1,447

Quick answer

1,447 indexed pharmaceutical patents have expiration dates in 2035. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9096653

    Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9096679

    Peptide compounds and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9096830

    Multi-layered hydrogel constructs and associated methods

    The Board of Regents of the University of Texas System · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9097713

    Monoclonal antibodies against glycoprotein of Ebola sudan boniface virus

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF USAMRMC · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9096625

    BCL-2/BCL-XL inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9096542

    Kinase inhibitors and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9096496

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9095622

    Oligomer-protein tyrosine kinase inhibitor conjugates

    Nektar Therapeutics · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9095593

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9095558

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    The Board of Regents of the University of Texas System · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9096517

    Oligomer-containing pyrrolidine compounds

    Nektar Therapeutics · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9095515

    Ezetimibe compositions

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9095539

    Anti-adhesin based passive immunoprophylactic

    United States of America as represented by the Secretary of the Air Force · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9095550

    Methods for treating diabetic wounds

    CALREGEN INC. · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9095571

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9095572

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9097707

    Photoreactive regulator of protein function and methods of use thereof

    The Regents of the University of California · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9095620

    Reagents

    Nektar Therapeutics · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9095562

    Methods and compositions for optimized expansion and implantation of mesenchymal stem cells

    REGENERATIVE SCIENCES, LLC · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9095579

    Protection and treatment against influenza infection

    The Regents of the University of California · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9095597

    N-acetyl mannosamine as a therapeutic agent

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9095621

    Oligome-bis-chromonyl compound conjugates

    Nektar Therapeutics · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9095612

    Halogenated compounds for photodynamic therapy

    NANOQUANTUM SCIENCES, INC. · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9095608

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9095629

    Magnetic nanostructures as theranostic agents

    Northwestern University · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9095624

    Modular transport platform for targeted delivery of therapeutic agents

    Contango Partners Group, Inc. · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9096501

    Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9096515

    Methods of using cycloalkylmethylamine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. CA 2938043

    MELANGE GAZEUX NO/HE A ACTION BACTERICIDE

    AIR LIQUIDE SANTE (INTERNATIONAL) [FR] · Granted Thu Aug 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Aug 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9102831

    Process for producing improved zein articles

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9102698

    Process for the synthesis of IB-MECA

    CAN-FITE BIOPHARMA LTD. · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9101612

    Secondary structure stabilized NMDA receptor modulators and uses thereof

    Northwestern University · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9102672

    Azaindole derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9102666

    Methods and drug products for treating Alzheimer's disease

    Takeda Pharmaceutical Company Limited · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9102752

    Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type

    United Biomedical, Inc. · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9102626

    Multifunctional radical quenchers for the treatment of mitochondrial dysfunction

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9102938

    2′ and 5′ modified monomers and oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9103826

    Methods and biomarkers for the detection of dengue hemorrhagic fever

    The Board of Regents of the University of Texas System · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9102660

    Process of making prostacyclin compounds with linker thiol and pegylated forms

    United Therapeutics Corporation · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9102948

    Regulating alkaloids

    22ND CENTURY LIMITED, LLC · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9101637

    Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity

    The Board of Regents of the University of Texas System · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9101643

    Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR)

    Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9101582

    Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9101565

    Dissolution stability of calcium carbonate tablets

    TAKEDA NYCOMED AS · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9101636

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Acurx Pharmaceuticals, Inc. · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9102620

    Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9101600

    Compounds as RORγt modulators and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9101575

    Methods of inhibiting vascular permeability and apoptosis

    UNIVERSITY OF CONNECTICUT · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2035?

1,447 published patents in our USPTO index have expiration dates falling in calendar year 2035.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.